Not available
Quote | Marinus Pharmaceuticals Inc. (NASDAQ:MRNS)
Last: | $1.51 |
---|---|
Change Percent: | -3.45% |
Open: | $1.5 |
Close: | $1.51 |
High: | $1.65 |
Low: | $1.48 |
Volume: | 1,603,749 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
News | Marinus Pharmaceuticals Inc. (NASDAQ:MRNS)
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that Scott Braunstein, M.D., Chairman and Chief Executive Officer, will be participating in a fireside chat at the RBC Capit...
Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial results for the first quarter ended March 31, 2024 before market open on May 8, 2024. ...
Message Board Posts | Marinus Pharmaceuticals Inc. (NASDAQ:MRNS)
Subject | By | Source | When |
---|---|---|---|
Did you add more here? This recovered | Cosa | investorshub | 04/19/2023 12:04:13 AM |
whytestocks: $MRNS News Article - Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for G | whytestocks | investorshangout | 03/22/2023 5:10:50 PM |
whytestocks: $MRNS News Article - Marinus Pharmaceuticals Appoints Christine Silverstein to its Boar | whytestocks | investorshangout | 01/30/2023 9:05:45 PM |
Thanks, I will look. | Cosa | investorshub | 01/23/2023 6:34:53 PM |
Ha, our time is coming for MRNS Cosa, | Ganz | investorshub | 01/20/2023 3:40:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Marinus Pharmaceuticals Inc. Company Name:
MRNS Stock Symbol:
NASDAQ Market:
Marinus Pharmaceuticals Inc. Website:
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that Scott Braunstein, M.D., Chairman and Chief Executive Officer, will be participating in a fireside chat at the RBC Capit...
Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial results for the first quarter ended March 31, 2024 before market open on May 8, 2024. ...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...